Barclays
ADGM

Barclays’s Adagio Medical Holdings ADGM Stock Holding History

Barclays’s Portfolio ADGM Stock Details ADGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15 Buy
+23
New +$22 ﹤0.01% 5293
2025
Q4 		– Sell
-14
Closed -$27 – 5790
2025
Q3 		$27 Buy
+14
New +$22 ﹤0.01% 5346
2025
Q2 		– Sell
-197
Closed -$159 – 5616
2025
Q1 		$159 Buy
+197
New +$209 ﹤0.01% 5121

Other funds holding ADGM

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's ADGM Position: Q2 2026 in Review

Barclays opened a new position in Adagio Medical Holdings (ADGM) in Q2 2026: 23 shares worth $15. The stake represents ﹤0.01% of the portfolio and ranks #5293 among its holdings. This is a return to the name: Barclays previously reported a position in ADGM as recently as Q3 2025.

Barclays first reported a position in ADGM in Q1 2025 and has held it in 3 quarters since. The position peaked at $159 in Q1 2025. 24 funds tracked by Wall St. Rank hold ADGM as of Q2 2026.

  • Barclays held 23 shares of Adagio Medical Holdings worth $15 as of Q2 2026.
  • Adagio Medical Holdings was a new Barclays position in Q2 2026.
  • Adagio Medical Holdings made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5293 holding.
  • Barclays first reported a position in Adagio Medical Holdings in Q1 2025 and has held it in 3 quarters since.
  • Barclays's Adagio Medical Holdings position peaked at $159 in Q1 2025.
  • 24 funds tracked by Wall St. Rank held Adagio Medical Holdings as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.